Arkadios Wealth Advisors

Position in MRNA — Moderna, Inc.

CIK 1800798 ATLANTA, GA

Back to MRNA Full portfolio

Position in MRNA

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$907,135

+$189,172 QoQ

Shares Held

17,857

-26.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2024

CallValue

$266,400

CallShares

2,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Arkadios Wealth Advisors holds $12,704,540 across 13 Biotechnology names. MRNA ranks #6 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	4,435	$3,426,657
2	JAZZ	Jazz Pharmaceuticals plc	11,960	$2,261,037
3	TYRA	Tyra Biosciences, Inc.	47,567	$1,821,816
4	VRTX	Vertex Pharmaceuticals Inc / Ma	3,684	$1,645,052
5	HALO	Halozyme Therapeutics, Inc.	19,622	$1,268,169
6	MRNA	Moderna, Inc. This page	17,857	$907,135
7	EXEL	Exelixis, Inc.	11,098	$475,992
8	CRSP	CRISPR Therapeutics AG	9,416	$447,918

All Filings in MRNA

Export CSV

35 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$907,135	17,857	-26.7%	Shares	Sole	2026-05-18
2025-12-31	$717,963	24,346	+85.4%	Shares	Sole	2026-02-13
2025-09-30	$339,172	13,131	+0.2%	Shares	Sole	2025-10-29
2025-06-30	$361,400	13,099	-7.4%	Shares	Sole	2025-08-04
2025-03-31	$400,982	14,144	+15.3%	Shares	Sole	2025-05-08
2024-12-31	$509,978	12,265	+7.3%	Shares	Sole	2025-01-15
2024-09-30	$763,800	11,429	+2.2%	Shares	Sole	2024-10-24
2024-06-30	$1,328,337	11,186	+347.4%	Shares	Sole	2024-07-29
2024-03-31	$266,400	2,500	-77.1%	Call	Sole	2024-04-30
2024-03-31	$1,161,930	10,904	+49.4%	Shares	Sole	2024-04-30
2023-12-31	$725,985	7,300	-37.8%	Call	Sole	2024-01-24
2023-12-31	$1,167,344	11,738	-6.0%	Shares	Sole	2024-01-24
2023-09-30	$1,289,988	12,489	+24.9%	Shares	Sole	2023-10-13
2023-09-30	$1,032,900	10,000	-19.4%	Call	Sole	2023-10-13
2023-06-30	$1,506,964	12,403	+148.1%	Shares	Sole	2023-07-26
2023-06-30	$607,500	5,000	0.0%	Call	Sole	2023-07-26
2023-03-31	$767,900	5,000	-62.2%	Call	Sole	2023-05-02
2023-03-31	$2,031,095	13,225	+429.0%	Shares	Sole	2023-05-02
2022-12-31	$449,050	2,500	-81.2%	Call	Sole	2023-01-11
2022-12-31	$2,393,795	13,327	-0.4%	Shares	Sole	2023-01-11
2022-09-30	$1,581,830	13,377	+167.5%	Shares	Sole	2022-10-21
2022-09-30	$591,250	5,000	-61.6%	Call	Sole	2022-10-21
2022-06-30	$1,860,906	13,027	-3.5%	Shares	Sole	2022-07-14
2022-06-30	$1,928,475	13,500	+80.0%	Call	Sole	2022-07-14
2022-03-31	$1,291,950	7,500	-42.4%	Call	Sole	2022-05-02
2022-03-31	$2,242,308	13,017	+7.5%	Shares	Sole	2022-05-02
2021-12-31	$3,074,681	12,106	-19.3%	Shares	Sole	2022-02-03
2021-12-31	$3,809,700	15,000	+27.2%	Call	Sole	2022-02-03
2021-09-30	$4,540,193	11,797	+2.3%	Shares	Sole	2021-10-19
2021-06-30	$2,708,614	11,527	+2.3%	Shares	Sole	2021-07-28
2021-03-31	$1,475,413	11,267	+49.6%	Shares	Sole	2021-04-26
2020-12-31	$786,868	7,532	+15.2%	Shares	Sole	2021-02-09
2020-09-30	$462,422	6,536	+69.8%	Shares	Sole	2020-11-10
2020-06-30	$247,208	3,850	+28.3%	Shares	Sole	2020-08-10
2020-03-31	$89,850	3,000	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.